Studies of new fused benzazepine as selective dopamine D3 receptor antagonists using 3D-QSAR, molecular docking and molecular dynamics
about
Investigation on quantitative structure activity relationships and pharmacophore modeling of a series of mGluR2 antagonistsBeyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug designPhysiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.Insights into the structural biology of G-protein coupled receptors impacts drug design for central nervous system neurodegenerative processes.Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors.Predicting subtype selectivity of dopamine receptor ligands with three-dimensional biologically relevant spectrum.
P2860
Studies of new fused benzazepine as selective dopamine D3 receptor antagonists using 3D-QSAR, molecular docking and molecular dynamics
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Studies of new fused benzazepi ...... docking and molecular dynamics
@en
Studies of new fused benzazepi ...... docking and molecular dynamics
@nl
type
label
Studies of new fused benzazepi ...... docking and molecular dynamics
@en
Studies of new fused benzazepi ...... docking and molecular dynamics
@nl
prefLabel
Studies of new fused benzazepi ...... docking and molecular dynamics
@en
Studies of new fused benzazepi ...... docking and molecular dynamics
@nl
P2093
P2860
P356
P1476
Studies of new fused benzazepi ...... docking and molecular dynamics
@en
P2093
Chunzhi Ai
Shuwei Zhang
Zhengtao Xiao
P2860
P304
P356
10.3390/IJMS12021196
P407
P577
2011-02-18T00:00:00Z